| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2024 ( Subtotal = $101,737,358 ) (Continued on the next page) |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | RC2DK140862 | Consortium on Intestinal Regeneration and Fetal Reversion: from Atlas to Therapy | 000 | 1 | NIH | 8/30/2024 | $2,000,000 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01HL175875 | AI-enabled characterization of fibrocalcific aortic valve disease and inflammation from CT Angiography: Patient-specific outcome prediction | 000 | 1 | NIH | 9/1/2024 | $810,650 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01HL174973 | PRC2 independent role of Ezh2 in regulation of basal cell dynamics post-influenza virus infection | 000 | 1 | NIH | 8/27/2024 | $563,141 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01DK141162 | Eicosanoids, Chronic Kidney Disease Progression, and Associated Cardiovascular Risk | 000 | 1 | NIH | 9/1/2024 | $892,433 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01AI184203 | Intra-graft C1 esterase inhibitor therapy for deceased kidney transplantation | 000 | 1 | NIH | 8/30/2024 | $2,216,525 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01HD113693 | Functional Genomics Across an Ethnically and Racially Diverse Endometriosis Population | 000 | 1 | NIH | 12/27/2023 | $607,397 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01AI175101 | Regulation of cellular functions and innate immunity by interleukin-1alpha | 001 | 1 | NIH | 9/4/2024 | $60,250 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01AI175101 | Regulation of cellular functions and innate immunity by interleukin-1alpha | 000 | 1 | NIH | 11/3/2023 | $542,249 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | K99AG084864 | Establishing reactive astrocyte memory as a risk factor for aging-related neurodegenerative disease | 000 | 1 | NIH | 7/26/2024 | $107,865 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R00HL157421 | Deep Learning Assessment of the Right Ventricle: Function, Etiology, and Prognosis | 000 | 4 | NIH | 1/22/2024 | $248,979 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01HD113693 | Functional Genomics Across an Ethnically and Racially Diverse Endometriosis Population | 001 | 1 | NIH | 7/29/2024 | -$607,396 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01DK140676 | Clinical Impact and Feasibility of Virtual Reality (VR) for Irritable Bowel Syndrome: A Pilot Randomized Controlled Trial Comparing VR Cognitive Behavioral Therapy vs. Sham VR | 000 | 1 | NIH | 7/17/2024 | $334,000 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R56HL175516 | Transcatheter vs. Surgical Treatment of Degenerative Mitral Regurgitation: A Comparative Study of Clinical Outcomes, Patient Experiences, and Mechanistic Insights with Multimodality Imaging | 000 | 1 | NIH | 8/1/2024 | $834,249 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R00HL153688 | MCEMP1 is an adaptor for KIT receptor for mast cell proliferation | 000 | 3 | NIH | 1/25/2024 | $249,000 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01HL167921 | Targeting myocardial fibrosis with a novel noncoding RNA in Duchenne muscular dystrophy | 001 | 1 | NIH | 6/6/2024 | $61,724 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01HL167921 | Targeting myocardial fibrosis with a novel noncoding RNA in Duchenne muscular dystrophy | 000 | 1 | NIH | 1/10/2024 | $555,531 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01HL172990 | Targeting WNT7A Signaling in Pulmonary Fibrosis | 000 | 1 | NIH | 7/23/2024 | $787,266 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01CA276448 | Role of AMPK in melanoma brain metastasis | 003 | 3 | NIH | 4/16/2024 | $33,551 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01CA276448 | Role of AMPK in melanoma brain metastasis | 002 | 3 | NIH | 1/5/2024 | $603,881 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R13LM014478 | AI-Campus Workshops: Revolutionizing Healthcare with AI and Machine Learning to Promote Diversity and Inclusion | 000 | 1 | NIH | 8/29/2024 | $20,000 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01HL160860 | A hypercholesterolemia-induced immunometabolite in atherosclerosis | 001 | 3 | NIH | 6/26/2024 | $48,627 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01HL160860 | A hypercholesterolemia-induced immunometabolite in atherosclerosis | 000 | 3 | NIH | 11/16/2023 | $547,071 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01DK130851 | Evaluating environmental control (AVOID) and inhibitory control (RESIST) strategies to improve weight management outcomes | 001 | 3 | NIH | 5/16/2024 | $42,950 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01DK130851 | Evaluating environmental control (AVOID) and inhibitory control (RESIST) strategies to improve weight management outcomes | 000 | 3 | NIH | 1/25/2024 | $644,243 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01AI164519 | ACE and myeloid cell metabolism | 002 | 3 | NIH | 7/25/2024 | $338,801 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01AI164519 | ACE and myeloid cell metabolism | 001 | 3 | NIH | 5/24/2024 | $56,043 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01AI164519 | ACE and myeloid cell metabolism | 000 | 3 | NIH | 1/17/2024 | $504,383 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01EY026944 | Therapeutic control of HSK by CD80 | 000 | 8 | NIH | 12/8/2023 | $417,500 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | P01CA233452 | Determinants of Liver Metastasis | 005 | 5 | NIH | 4/16/2024 | $8,285 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | P01CA233452 | Determinants of Liver Metastasis | 004 | 5 | NIH | 4/16/2024 | $89,345 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | P01CA233452 | Determinants of Liver Metastasis | 003 | 5 | NIH | 1/25/2024 | $149,159 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | P01CA233452 | Determinants of Liver Metastasis | 002 | 5 | NIH | 1/24/2024 | $1,607,969 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01LM014572 | Knowledge-guided automated machine learning methods for modeling the interaction of HIV with addictive drugs | 000 | 1 | NIH | 6/28/2024 | $508,201 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01CA292654 | A translational study of a synthetic lethality interaction of CD105 and androgen receptor signaling axis for castration-resistant prostate cancer patients | 000 | 1 | NIH | 6/21/2024 | $553,550 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01DK080834 | Inhibition of an Apical cAMP/cGMP Transporter (MRP4) in the Gut Induces Diarrhea | 000 | 17 | NIH | 5/21/2024 | $606,584 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01MH136492 | SARS-CoV-2 and Social Determinants of Health Impact on Inflammation Associated Depression Risk (SSIDR) | 000 | 1 | NIH | 7/3/2024 | $833,123 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01NS131782 | Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia | 001 | 1 | NIH | 8/14/2024 | $44,559 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01NS131782 | Defining the role of Tox3 in congenital cerebellar hypoplasia and ataxia | 000 | 1 | NIH | 7/8/2024 | $462,744 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | F32AI183661 | Defining the role of PSTPIP2 in neutrophil biology | 000 | 1 | NIH | 6/18/2024 | $73,828 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01HL173526 | Deep Learning Based Phenotyping and Outcomes Prediction for Valvular Heart Disease | 001 | 1 | NIH | 6/10/2024 | $83,378 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01HL173526 | Deep Learning Based Phenotyping and Outcomes Prediction for Valvular Heart Disease | 000 | 1 | NIH | 4/1/2024 | $750,403 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | T32HL170963 | Multidisciplinary Pulmonary Research Training Program | 001 | 1 | NIH | 8/15/2024 | $13,083 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | T32HL170963 | Multidisciplinary Pulmonary Research Training Program | 000 | 1 | NIH | 4/1/2024 | $200,495 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R21HD110129 | Impaired Renal Reserve and Preeclampsia | 000 | 1 | NIH | 7/12/2024 | $250,500 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01CA280060 | Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer | 001 | 2 | NIH | 8/19/2024 | $657,403 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01CA283313 | Mechanistic studies of hirsutinolides and azetidine based small molecule inhibitors of STAT3 | 001 | 1 | NIH | 8/19/2024 | $128,902 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R01CA283313 | Mechanistic studies of hirsutinolides and azetidine based small molecule inhibitors of STAT3 | 000 | 1 | NIH | 3/26/2024 | $703,595 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1865 | LOS ANGELES | USA | R01AR082041 | Studying the mechanism of discogenic low back pain induction. | 000 | 1 | NIH | 5/21/2024 | $534,382 |
| 2024 | 2024 | CEDARS-SINAI MEDICAL CENTER | 8700 BEVERLY BLVD | WEST HOLLYWOOD | CA | 90048-1804 | LOS ANGELES | USA | R33CA278564 | Enabling in vivo barcoded single-cell multiomics-compatible genome-wide screens in personalized tumor models using defined-copy somatic transgenesis | 000 | 1 | NIH | 2/8/2024 | $414,491 |
|